SIRT1 expression was reduced in patients with systemic sclerosis and TGF-β-dependent experimental fibrosis patients, but this reduction was not sufficient to counteract the excessive activation of TGF-β signalling in systemic sclerosis. This evidence concerns the gene TGFB1 and fibrosis.